Hepatocellular carcinoma (HCC) is a common and deadly cancer whose pathogenesis is incompletely understood. Comparative genomic studies from human HCC samples have classified HCCs into different molecular subgroups; yet, the unifying feature of this tumor is its propensity to arise upon a background of inflammation and fibrosis. This review seeks to analyze the available experimental models in HCC research and to correlate data from human populations with them in order to consolidate our efforts to date, as it is increasingly clear that different models will be required to mimic different subclasses of the neoplasm. These models will be instrumental in the evaluation of compounds targeting specific molecular pathways in future preclinical s...
Le carcinome hépatocellulaire (CHC), souvent diagnostiqué tardivement, est un cancer extrêmement agr...
Hepatocellular carcinoma (HCC) represents a major and steadily increasing global health challenge as...
Hepatocellular carcinomas (HCCs) have different etiology and heterogenic genomic alterations lead to...
Hepatocellular carcinoma (HCC) is a common and deadly cancer whose pathogenesis is incompletely unde...
Hepatocellular carcinoma (HCC), the most frequent form of primary liver carcinoma, is a heterogenous...
Every year almost 500,000 new patients are diagnosed with hepatocellular carcinoma (HCC), a primary ...
Hepatocellular carcinoma (HCC) is a major and increasing cause of clinical and economic burden world...
In addition to being the most common primary liver cancer, hepatocellular carcinoma (HCC) is the sec...
Abstract Hepatocellular carcinoma (HCC) has become a severe burden on global health due to its high ...
Hepatocellular carcinoma (HCC) is one of the most fatal and fastest-growing cancers. Recently, non-a...
Murine liver tumors often fail to recapitulate the complexity of human hepatocellular carcinoma (HCC...
Hepatocellular carcinoma is the fifth most common cancer worldwide. Studies of the molecular mechani...
Hepatocellular carcinoma (HCC) is a deadly disease, often unnoticed until the late stages, when trea...
Murine liver tumors often fail to recapitulate the complexity of human hepatocellular carcinoma (HCC...
In addition to being the most common primary liver cancer, hepatocellular carcinoma (HCC) is the sec...
Le carcinome hépatocellulaire (CHC), souvent diagnostiqué tardivement, est un cancer extrêmement agr...
Hepatocellular carcinoma (HCC) represents a major and steadily increasing global health challenge as...
Hepatocellular carcinomas (HCCs) have different etiology and heterogenic genomic alterations lead to...
Hepatocellular carcinoma (HCC) is a common and deadly cancer whose pathogenesis is incompletely unde...
Hepatocellular carcinoma (HCC), the most frequent form of primary liver carcinoma, is a heterogenous...
Every year almost 500,000 new patients are diagnosed with hepatocellular carcinoma (HCC), a primary ...
Hepatocellular carcinoma (HCC) is a major and increasing cause of clinical and economic burden world...
In addition to being the most common primary liver cancer, hepatocellular carcinoma (HCC) is the sec...
Abstract Hepatocellular carcinoma (HCC) has become a severe burden on global health due to its high ...
Hepatocellular carcinoma (HCC) is one of the most fatal and fastest-growing cancers. Recently, non-a...
Murine liver tumors often fail to recapitulate the complexity of human hepatocellular carcinoma (HCC...
Hepatocellular carcinoma is the fifth most common cancer worldwide. Studies of the molecular mechani...
Hepatocellular carcinoma (HCC) is a deadly disease, often unnoticed until the late stages, when trea...
Murine liver tumors often fail to recapitulate the complexity of human hepatocellular carcinoma (HCC...
In addition to being the most common primary liver cancer, hepatocellular carcinoma (HCC) is the sec...
Le carcinome hépatocellulaire (CHC), souvent diagnostiqué tardivement, est un cancer extrêmement agr...
Hepatocellular carcinoma (HCC) represents a major and steadily increasing global health challenge as...
Hepatocellular carcinomas (HCCs) have different etiology and heterogenic genomic alterations lead to...